DYRK1B and colon carcinoma: To test this hypothesis, the effect of knockdown of Mirk by synthetic duplex RNAi was tested in two stably transfected clones of the HD3 colon carcinoma cell line, the vector control transfectant and stable Mirk T10 transfectant expressing more Mirk protein [12].